EU Sets New Migration Limits for Food Packaging

On July 23, 2026, the European Commission issued Regulation (EU) 2026/1482, updating migration limits for food contact plastics and regenerated cellulose film under the framework of (EC) No 1935/2004. For manufacturers exporting packaging materials to the EU, including Chinese suppliers, this is not just a regulatory update but a direct customs and compliance issue: products shipped without a Declaration of Conformity (DoC) and third-party migration test reports face the risk of being refused clearance from September 2026 onward. What deserves closer attention is how this change affects material selection, documentation readiness, and delivery execution across the packaging supply chain.

What the new EU rule formally changes

The confirmed facts are clear. Regulation (EU) 2026/1482 was published by the European Commission on July 23, 2026. It revises the specific migration limits (SML) applicable to food contact plastics and regenerated cellulose film under the broader framework of (EC) No 1935/2004.

The update adds controls on nonylphenol, bisphenol S, and three new bio-based plasticizers. The rule applies to all manufacturers exporting packaging materials to the EU market, including suppliers based in China.

Another confirmed point is the documentation threshold for market entry. Products that do not have a Declaration of Conformity and third-party migration testing reports will be rejected at customs clearance.

Where pressure is likely to build across the supply chain

Export packaging producers face immediate compliance exposure

From an industry perspective, packaging manufacturers that sell directly into the EU are the first group likely to feel the impact. Their exposure is tied to whether existing formulations, finished materials, and supporting technical files can meet the revised SML requirements. The main pressure points are product compliance review, test arrangement, and shipment documentation completeness.

Raw material and additive sourcing will come under closer review

For companies involved in material procurement, the rule matters because the newly controlled substances include nonylphenol, bisphenol S, and three bio-based plasticizers. Analysis shows that procurement teams will need to pay closer attention to whether upstream material information is sufficient to support migration compliance claims. The effect is likely to appear in supplier screening, formulation checks, and document collection rather than only in finished-goods testing.

Trade and customs-facing businesses may see execution risk rise

For traders, import-export operators, and supply chain service providers, the issue is practical rather than theoretical. The summary provided makes clear that products lacking a DoC and third-party migration test reports can be denied customs clearance. That means compliance risk may surface at the point of shipment, customs filing, or delivery commitment, especially where documentation is incomplete or obtained too late in the order cycle.

EU-facing buyers and downstream users will likely tighten document requirements

Observably, downstream buyers using imported packaging materials for EU-related business may place greater emphasis on proof of conformity. Even where the regulation targets market entry conditions, its operational effect can extend into supplier qualification, order confirmation, and pre-delivery checks.

What companies should watch now

Do not treat product testing and customs documents as separate tasks

The rule links technical compliance with actual border access. In practice, companies should pay attention to whether internal compliance review, third-party migration testing, and shipment documentation are being managed as one process rather than as separate late-stage tasks.

Focus first on materials that may involve the newly controlled substances

What deserves closer attention is not every material in the same way, but the products and formulations that may involve nonylphenol, bisphenol S, or the newly controlled bio-based plasticizers. This is where review priorities are most likely to concentrate.

Check whether supplier files can support a valid DoC

The summary indicates that a Declaration of Conformity is essential for customs clearance. That makes supplier document quality a practical business issue. Companies should pay attention to whether upstream technical statements, composition-related information, and test support are sufficient to sustain a compliant declaration.

Prepare for customer communication around timing and deliverables

Analysis shows that the commercial impact may appear in lead times and shipment readiness as much as in product approval. Exporters and service providers should therefore watch for requests related to testing schedules, report availability, and documentation status when communicating with EU customers and partners.

Why this matters beyond a single rule update

This section is an observation rather than a statement of fact. It is more appropriate to understand this development as both an immediate compliance change and a longer-term regulatory signal. The immediate part is straightforward: from September 2026, missing DoC and third-party migration reports can directly interrupt customs clearance. The longer-term signal is that food contact material compliance is being enforced not only through substance control but also through documentation discipline.

Observably, the update is especially relevant for suppliers that serve the EU market through cross-border packaging orders, because the regulatory requirement can translate quickly into shipment risk. At the same time, the information provided does not confirm wider market outcomes, so broader conclusions should remain under review.

How this update is best understood at this stage

At this stage, the development is best read as a concrete compliance requirement with immediate operational consequences for EU-bound packaging materials, rather than as a broad market conclusion. The confirmed facts already point to two clear realities: certain substances now face tighter migration control, and customs access depends on both a DoC and third-party migration testing. From an industry perspective, the significance lies in execution readiness across materials, documentation, and delivery processes.

It is more appropriate to understand this as an actionable regulatory change with continuing implications, especially for exporters and suppliers whose EU business depends on smooth customs clearance and defensible compliance files.

Basis of this article and points that still require verification

This article is based on the user-provided news title, event date, and event summary. The confirmed information used here comes from the provided description of Regulation (EU) 2026/1482, its publication date of July 23, 2026, the substances newly brought under control, the stated scope covering exporters to the EU including Chinese suppliers, and the customs consequence for products lacking a DoC and third-party migration test reports.

For this type of industry update, source categories commonly relevant include official regulatory notices, company compliance notices, industry association updates, authoritative media coverage, and standards-related documents. A specific official source link was not provided in the input, so the exact official publication path still requires ongoing verification. Follow-up attention should remain on any further official wording, interpretive guidance, or implementation-related clarifications connected to this rule.